GLENN L MD COOPER Insider Trading $IDEV Endo Pharmaceuticals Solutions Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GLENN L MD COOPER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GLENN L MD COOPER. GLENN L MD COOPER is President and CEO in Endo Pharmaceuticals Solutions Inc. ($IDEV) and Director in REPLIGEN CORP ($RGEN).
GLENN L MD COOPER in Endo Pharmaceuticals Solutions Inc.
Trading Symbol: IDEVIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GLENN L MD COOPER: President and CEO
Holdings: 185,000 shares
Latest Transaction: Mar 11 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GLENN L MD COOPER in Endo Pharmaceuticals Solutions Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 11 2005 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 3.70 | 75,000 | 277,500 | 75,000 | |
Feb 16 2005 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Buy | P | 4.05 | 10,000 | 40,500 | 185,000 | 175 K to 185 K (+5.71 %) |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 5.00 | 60,000 | 300,000 | 60,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 5.00 | 60,000 | 300,000 | 0 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 4.16 | 60,000 | 249,600 | 60,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 4.16 | 60,000 | 249,600 | 0 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 6.19 | 800,000 | 4,952,000 | 800,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 6.19 | 800,000 | 4,952,000 | 0 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 4.16 | 300,000 | 1,248,000 | 300,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 4.16 | 300,000 | 1,248,000 | 0 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 5.00 | 60,000 | 300,000 | 60,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 5.00 | 60,000 | 300,000 | 0 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 4.16 | 60,000 | 249,600 | 60,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 4.16 | 60,000 | 249,600 | 0 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 6.19 | 800,000 | 4,952,000 | 800,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 6.19 | 800,000 | 4,952,000 | 0 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 4.16 | 300,000 | 1,248,000 | 300,000 | |
Sep 16 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | D | 4.16 | 300,000 | 1,248,000 | 0 | |
Mar 12 2004 | IDEV | Endo Pharmaceutica ... | COOPER GLENN L MD | President and CEO | Option Exercise | A | 5.92 | 150,000 | 888,000 | 150,000 |
Page: 1